多家公募调整停牌股估值方式；超百只ETF流动性告急？丨天赐良基早参

Group 1 - Wang Chongkun has been appointed as the new Chief Inspector of Vanguard Fund, succeeding Huang Jinsong who has retired [1] - Yuan Qingwei has been appointed as the new General Manager of China Merchants Sheldon's Fund, with a background in various senior roles at China Communications Bank [2][3] - The establishment of a wholly-owned subsidiary, E Fund Wealth, has been approved by the CSRC, marking E Fund's entry into the wealth management sector [4] Group 2 - Over a hundred ETFs are facing liquidity issues, with some funds warning of potential liquidation due to low asset values [5][6] - As of June 5, 147 out of 1179 ETFs had assets below 50 million yuan, indicating significant liquidity challenges [7] - More than twenty public fund companies have announced a change in the valuation method for suspended stocks, adopting the "index income method" for valuation [8][9] Group 3 - Fund manager Zhou Sicong predicts that 2025 will be a pivotal year for China's innovative drug industry, marking a year of revenue growth, profitability, and valuation increases [10] - The innovative drug sector in China has evolved through three significant phases, and companies are now entering new treatment areas while achieving profitability [10] Group 4 - The previous trading day saw the market rise, with the Shanghai Composite Index increasing by 0.43% and the Shenzhen Component Index by 0.65%, indicating positive market sentiment [11] - The Hong Kong innovative drug ETF performed strongly, with a peak increase of 4.72% [11]